246 related articles for article (PubMed ID: 34910926)
1. Cathepsin S is a novel target for age-related dry eye.
Yu Z; Li J; Govindarajan G; Hamm-Alvarez SF; Alam J; Li DQ; de Paiva CS
Exp Eye Res; 2022 Jan; 214():108895. PubMed ID: 34910926
[TBL] [Abstract][Full Text] [Related]
2. Effects of Cathepsin S Inhibition in the Age-Related Dry Eye Phenotype.
Galletti JG; Scholand KK; Trujillo-Vargas CM; Haap W; Santos-Ferreira T; Ullmer C; Yu Z; de Paiva CS
Invest Ophthalmol Vis Sci; 2023 Aug; 64(11):7. PubMed ID: 37540176
[TBL] [Abstract][Full Text] [Related]
3. Imbalanced IL-37/TNF-α/CTSS signaling disrupts corneal epithelial barrier in a dry eye model in vitro.
Zhang Y; Li JM; Lu R; Liu Z; Chen X; de Paiva CS; Pflugfelder SC; Li DQ
Ocul Surf; 2022 Oct; 26():234-243. PubMed ID: 36208723
[TBL] [Abstract][Full Text] [Related]
4. Phenylephrine increases tear cathepsin S secretion in healthy murine lacrimal gland acinar cells through an alternative secretory pathway.
Fu R; Janga S; Edman MC; Hamm-Alvarez SF
Exp Eye Res; 2021 Oct; 211():108760. PubMed ID: 34487726
[TBL] [Abstract][Full Text] [Related]
5. 0.005% Preservative-Free Latanoprost Induces Dry Eye-Like Ocular Surface Damage via Promotion of Inflammation in Mice.
Yang Y; Huang C; Lin X; Wu Y; Ouyang W; Tang L; Ye S; Wang Y; Li W; Zhang X; Liu Z
Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3375-3384. PubMed ID: 30025085
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Effect of MK2 Inhibitor on Experimental Murine Dry Eye.
Wu Y; Bu J; Yang Y; Lin X; Cai X; Huang C; Zheng X; Ouyang W; Li W; Zhang X; Liu Z
Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4898-4907. PubMed ID: 28973340
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Effects of STAT3 Inhibition on Experimental Murine Dry Eye.
Qu M; Qi X; Wang Q; Wan L; Li J; Li W; Li Y; Zhou Q
Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3776-3785. PubMed ID: 31503282
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin S activation contributes to elevated CX3CL1 (fractalkine) levels in tears of a Sjögren's syndrome murine model.
Fu R; Guo H; Janga S; Choi M; Klinngam W; Edman MC; Hamm-Alvarez SF
Sci Rep; 2020 Jan; 10(1):1455. PubMed ID: 31996771
[TBL] [Abstract][Full Text] [Related]
9. Protection of human corneal epithelial cells from TNF-α-induced disruption of barrier function by rebamipide.
Kimura K; Morita Y; Orita T; Haruta J; Takeji Y; Sonoda KH
Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2572-760. PubMed ID: 23482463
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma deficiency protects against aging-related goblet cell loss.
Volpe EA; Henriksson JT; Wang C; Barbosa FL; Zaheer M; Zhang X; Pflugfelder SC; de Paiva CS
Oncotarget; 2016 Oct; 7(40):64605-64614. PubMed ID: 27623073
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome.
Klinngam W; Janga SR; Lee C; Ju Y; Yarber F; Shah M; Guo H; Wang D; MacKay JA; Edman MC; Hamm-Alvarez SF
Sci Rep; 2019 Jul; 9(1):9559. PubMed ID: 31267034
[TBL] [Abstract][Full Text] [Related]
12. Imbalanced Rab3D versus Rab27 increases cathepsin S secretion from lacrimal acini in a mouse model of Sjögren's Syndrome.
Meng Z; Edman MC; Hsueh PY; Chen CY; Klinngam W; Tolmachova T; Okamoto CT; Hamm-Alvarez SF
Am J Physiol Cell Physiol; 2016 Jun; 310(11):C942-54. PubMed ID: 27076615
[TBL] [Abstract][Full Text] [Related]
13. TNF is a critical cytokine in age-related dry eye disease.
Kelagere Y; Scholand KK; DeJong EN; Boyd AI; Yu Z; Astley RA; Callegan MC; Bowdish DM; Makarenkova HP; de Paiva CS
Ocul Surf; 2023 Oct; 30():119-128. PubMed ID: 37634571
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of topical adiponectin in a mouse model of desiccating stress-induced dry eye.
Li Z; Woo JM; Chung SW; Kwon MY; Choi JS; Oh HJ; Yoon KC
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):155-62. PubMed ID: 23211823
[TBL] [Abstract][Full Text] [Related]
15. Aim2 Deficiency Ameliorates Lacrimal Gland Destruction and Corneal Epithelium Defects in an Experimental Dry Eye Model.
Chen Y; Pu J; Li X; Lian L; Ge C; Liu Z; Wang W; Hou L; Chen W; Li J
Invest Ophthalmol Vis Sci; 2023 Mar; 64(3):26. PubMed ID: 36920364
[TBL] [Abstract][Full Text] [Related]
16. Time course of ocular surface and lacrimal gland changes in a new scopolamine-induced dry eye model.
Viau S; Maire MA; Pasquis B; Grégoire S; Fourgeux C; Acar N; Bretillon L; Creuzot-Garcher CP; Joffre C
Graefes Arch Clin Exp Ophthalmol; 2008 Jun; 246(6):857-67. PubMed ID: 18357464
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the mineral oil and hyaluronic acid mixture eye drops in murine dry eye.
Choi JH; Kim JH; Li Z; Oh HJ; Ahn KY; Yoon KC
Korean J Ophthalmol; 2015 Apr; 29(2):131-7. PubMed ID: 25829831
[TBL] [Abstract][Full Text] [Related]
18. Effects of Quercetin in a Mouse Model of Experimental Dry Eye.
Oh HN; Kim CE; Lee JH; Yang JW
Cornea; 2015 Sep; 34(9):1130-6. PubMed ID: 26203745
[TBL] [Abstract][Full Text] [Related]
19. Tear cathepsin S as a candidate biomarker for Sjögren's syndrome.
Hamm-Alvarez SF; Janga SR; Edman MC; Madrigal S; Shah M; Frousiakis SE; Renduchintala K; Zhu J; Bricel S; Silka K; Bach D; Heur M; Christianakis S; Arkfeld DG; Irvine J; Mack WJ; Stohl W
Arthritis Rheumatol; 2014 Jul; 66(7):1872-81. PubMed ID: 24644101
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin S Alters the Expression of Pro-Inflammatory Cytokines and MMP-9, Partially through Protease-Activated Receptor-2, in Human Corneal Epithelial Cells.
Klinngam W; Fu R; Janga SR; Edman MC; Hamm-Alvarez SF
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
